- Home
- SLQT vs ANAB Comparison
SLQT vs ANAB Comparison
Compare SLQT & ANAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLQT
- ANAB
- Stock Information
- Founded
- SLQT 1999
- ANAB 2005
- Country
- SLQT United States
- ANAB United States
- Employees
- SLQT N/A
- ANAB N/A
- Industry
- SLQT Specialty Insurers
- ANAB Biotechnology: Pharmaceutical Preparations
- Sector
- SLQT Finance
- ANAB Health Care
- Exchange
- SLQT Nasdaq
- ANAB Nasdaq
- Market Cap
- SLQT 566.4M
- ANAB 621.1M
- IPO Year
- SLQT 2020
- ANAB 2017
- Fundamental
- Price
- SLQT $2.23
- ANAB $23.17
- Analyst Decision
- SLQT Hold
- ANAB Buy
- Analyst Count
- SLQT 2
- ANAB 10
- Target Price
- SLQT $3.38
- ANAB $44.25
- AVG Volume (30 Days)
- SLQT 887.2K
- ANAB 775.6K
- Earning Date
- SLQT 05-12-2025
- ANAB 08-04-2025
- Dividend Yield
- SLQT N/A
- ANAB N/A
- EPS Growth
- SLQT N/A
- ANAB N/A
- EPS
- SLQT N/A
- ANAB N/A
- Revenue
- SLQT $1,488,701,000.00
- ANAB $111,872,000.00
- Revenue This Year
- SLQT $17.72
- ANAB N/A
- Revenue Next Year
- SLQT $13.05
- ANAB $24.39
- P/E Ratio
- SLQT N/A
- ANAB N/A
- Revenue Growth
- SLQT 20.41
- ANAB 387.20
- 52 Week Low
- SLQT $1.62
- ANAB $12.21
- 52 Week High
- SLQT $6.86
- ANAB $41.31
- Technical
- Relative Strength Index (RSI)
- SLQT 44.26
- ANAB 56.01
- Support Level
- SLQT $2.18
- ANAB $22.46
- Resistance Level
- SLQT $2.31
- ANAB $24.17
- Average True Range (ATR)
- SLQT 0.09
- ANAB 1.72
- MACD
- SLQT 0.04
- ANAB -0.01
- Stochastic Oscillator
- SLQT 51.02
- ANAB 73.23
About SLQT SelectQuote Inc.
SelectQuote Inc is a Direct-to-consumer (DTC) distribution platform which facilitates consumers to shop for health, life and auto & home insurance policies online. The company generates its revenues by selling insurance products on behalf of the insurance carrier partners in the form of a commission. It has four reportable segments namely Senior, Healthcare Services, Life, and Auto & Home. It functions through three lines namely, SelectQuote Senior, SelectQuote Life, and SelectQuote Auto & Home.
About ANAB AnaptysBio Inc.
AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).